To include your compound in the COVID-19 Resource Center, submit it here.

Biocon’s Mazumdar-Shaw pledges cheaper insulin for low income countries

Low and middle income countries would be able to purchase recombinant human insulin at a fraction of the current cost under a commitment by the founder of Indian biopharma Biocon, Kiran Mazumdar-Shaw.

The current median price

Read the full 357 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE